Why the study?
Does a co-existing non-IRA CTO increase the risk of contrast-associated nephropathy in STEMI patients managed with primary PCI?
Does a co-existing non-IRA CTO increase the risk of contrast-associated nephropathy in STEMI patients managed with primary PCI?
Answers are grounded in this paper and cite their sources.
In STEMI patients undergoing primary PCI, the presence of a non-infarct-related artery chronic total occlusion is independently associated with the development of contrast-associated nephropathy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Gök et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: